Bleichroeder LP Reports New 9.99% Stake in Envoy Medical, Inc. (COCH)

On May 14, 2026, Bleichroeder LP, alongside Bleichroeder Holdings LLC and Andrew Gundlach, filed a Schedule 13G reporting a significant new position in Envoy Medical, Inc. (COCH). The reporting persons disclosed beneficial ownership of 7,839,000 shares of Class A common stock, representing a 9.99% stake in the company. This position includes 6,250,000 shares of common stock and 1,589,000 shares issuable upon the exercise of warrants. Notably, the filing highlights a Beneficial Ownership Limitation within the Warrant Agreement that caps their exercisable ownership at 9.99%. Without this restriction, the reporting persons would hold 16,250,000 shares, including 10,000,000 warrant shares, which would equate to approximately 18.7% of the outstanding common stock. The securities were acquired in the ordinary course of business and not for the purpose of influencing control over the issuer. Andrew Gundlach serves as the President and CEO of the filing entities.